Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
Levofloxacin (LEV) is a relatively new-generation fluoroquinolone antibiotic that has good activity against <em>Mycobacterium tuberculosis</em>. The aims of this study were to develop and evaluate LEV-proliposomes in a dry powder aerosol form for pulmonary delivery. LEV-p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2012-08-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1999-4923/4/3/385 |